Artificial intelligence is being incorporated into more places in healthcare, for uses such as guiding clinical trial enrollment as well as helping physicians get up to speed on a patient’s history. A panel discussed these applications and more during MedCity News’s INVEST conference in Chicago. The post AI Is Finding Broader Use in in Healthcare,…
In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come. The post MedCity Pivot Podcast: Precision Medicine with the CEO of Helix appeared first on MedCity News.
Inaccurate provider data is creating a hidden crisis in healthcare by delaying care and driving up costs for both patients and health plans, according to CAQH CEO Sarah Ahmad. Her organization is working to address the issue by improving how provider data is collected and verified on the front end. The post Bad Provider Data…
As real-time inference overtakes training-centric approaches, a pivotal question emerges: how can the human element remain central in an increasingly autonomous ecosystem? The post The Future of AI in Healthcare Demands Transparency, Trust, and Human-Centered Design appeared first on MedCity News.
While prior authorization has made many headlines over the past year, concurrent review has not. Yet missteps in both processes leave hospitals in danger of not getting paid, which can result in higher costs being passed down to patients. The post What is Concurrent Review? appeared first on MedCity News.
Virtual solutions for depression and anxiety can lead to clinically meaningful outcomes, but certain pricing models may increase costs for employers and health plans, according to the Peterson Health Technology Institute. The post PHTI: Digital Mental Health Solutions Work, But Can Be Costly appeared first on MedCity News.
GSK drug Nucala has expanded its FDA-approved uses to include maintenance treatment of chronic obstructive pulmonary disease that’s driven by eosinophils, a type of immune cell. The antibody drug will compete against the blockbuster Sanofi product Dupixent, which expanded its FDA approval to COPD last year. The post GSK Inflammation Drug Lands New FDA Nod…
Startup finalists competed in four tracks: biopharma; devices and diagnostics; health tech aimed at consumers and self-insured employers; and health tech aimed at payers and providers. Investor judges in each track selected the winners. The post Who Won MedCity INVEST Pitch Perfect? appeared first on MedCity News.
The Alzheimer’s disease drugs that have reached the market in the past two years are antibodies designed to break up amyloid plaques. Vigil Neuroscience brings to Sanofi a different approach: an oral small molecule designed to activate microglia, immune cells that play a key role in brain health. The post Sanofi’s Neuro Pipeline Expands to…
Beyond the human cost, workplace violence carries significant economic consequences for healthcare institutions. Addressing this issue through virtual technology represents not just an ethical imperative but a financial one. The post Hidden in Plain Sight: How Existing Hospital Technology Can Prevent Workplace Violence appeared first on MedCity News.